Search Ontology:
ChEBI

N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine

Term ID
CHEBI:61818
Synonyms
  • (5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-nonulopyranosylonic acid)-(2->6)-2-acetamido-2-deoxy-alpha-D-galactopyranose
  • 2-(acetylamino)-6-O-[5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl]-2-deoxy-alpha-D-galactopyranose
  • 2-(acetylamino)-6-O-{(6R)-5-(acetylamino)-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl}-2-deoxy-alpha-D-galactopyranose
  • 2-acetamido-6-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-2-deoxy-alpha-D-galactopyranose
  • alpha-D-galactopyranose, 2-(acetylamino)-6-O-[5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl]-2-deoxy-
  • alpha-Neup5Ac-(2->6)-alpha-D-GalpNAc
  • Neu5Aca2-6GalNAca
  • Neu5Acalpha2-6GalNAcalpha
  • NeuAc(alpha->6)GalNAc(alpha-OH)
  • sialosyl-Tn antigen saccharide
  • sialosyl-Tn saccharide
Definition
An N-acetyl-α-neuraminyl-(2→6)-N-acetyl-D-galactosamine in which the carbon bearing the anomeric hydroxy group has α configuration.
References
  • glygen:G36123IU
  • glytoucan:G36123IU
  • pubmed:19443021
  • pubmed:25568069
  • pubmed:2800471
  • pubmed:28632300
  • pubmed:31537530
  • reaxys:8815709
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
Phenotype where environments contain N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
Phenotype modified by environments containing N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
Phenotype affecting N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine
Human Disease Model